The association of BRCA1 and BRCA2 mutations with prostate cancer risk, frequency, and mortality: A meta‐analysis

Background A prior meta‐analysis found no association between BRCA1 mutation and prostate cancer (PCa). Subsequent BRCA2 mutation studies have shown an association with PCa risk and mortality. We conducted a meta‐analysis of overall BRCA mutation carriers and in subgroups to (1) estimate PCa risk in...

Ausführliche Beschreibung